Andrew C. Jackson - 31 May 2022 Form 3 Insider Report for Brooklyn ImmunoTherapeutics, Inc. (ERNA)

Role: Chief Financial Officer
Signature: /s/ Andrew Jackson
Issuer symbol: ERNA
Transactions as of: 31 May 2022
Net transactions value: $0
Form type: 3
Filing time: 01 Jun 2022, 17:00:32 UTC
Previous filing: 24 May 2022
Next filing: 06 Jun 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

See Exhibit 24.1 - Power of Attorney